X0306 4 2014-06-02 0 0001048477 BIOMARIN PHARMACEUTICAL INC BMRN 0001557533 Ajer Jeffrey Robert C/O BIOMARIN PHARMACEUTICAL INC., 105 DIGITAL DRIVE NOVATO CA 94949 0 1 0 0 SVP, Chief Commercial Of Common Stock 2014-06-02 2014-06-02 4 S 0 377 57.8347 D 20190 D Transaction made pursuant to a Rule 10b5-1 plan executed on December 12, 2013. The price in Column 4 is a weighted average price. The prices actually received ranged from $57.50 to $58.22. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. /s/ Laura Randall Woodhead, Attorney-in-Fact 2014-06-03